{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:19:10Z","timestamp":1753888750377,"version":"3.41.2"},"reference-count":33,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006181","name":"Fundacao de Amparo a Pesquisa do Estado da Bahia","doi-asserted-by":"crossref","award":["SUS0017\/2021"],"award-info":[{"award-number":["SUS0017\/2021"]}],"id":[{"id":"10.13039\/501100006181","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006181","name":"Fundacao de Amparo a Pesquisa do Estado da Bahia","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100006181","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior","award":["SUS0017\/2021"],"award-info":[{"award-number":["SUS0017\/2021"]}]},{"name":"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior","award":["001"],"award-info":[{"award-number":["001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"abstract":"<jats:p>ABSTRACT Early diagnosis plays a pivotal role in breaking the epidemiological chain of Mycobacterium leprae transmission. Currently, diagnosis relies on clinical, dermato-neurological features, and histological\/microbiological assessments. This prospective cross-sectional study investigated whether IgA, IgM, and IgG anti-lipid antibodies can be used to improve the diagnostic performance for leprosy-affected patients in a high-burden municipality in Brazil. Serum samples from 91 volunteers, including patients with leprosy (n=62), household contacts (n=21), and endemic controls (n=8) were screened by enzyme-linked immunosorbent assays (ELISA) for IgA, IgM, and total IgG against four lipids\u2014namely, cardiolipin (CL), phosphatidylcholine (PTC), phosphatidylethanolamine (PE), and phosphatidylinositol (PI)\u2014and a glycosphingolipid\u2014sulfatide (SL)\u2014found in the bacterial cell wall. Antibodies against all lipids were detected in the sera of patients with leprosy. Significantly higher levels of IgA anti-CL, anti-PE, and anti-PTC, IgM anti-CL, and total IgG anti-PTC were observed in these patients compared to household contacts and endemic controls (p &lt; 0.0001). ROC curve analyses demonstrated high accuracy in discriminating patients with leprosy from the contacts, with moderate to high sensitivity and specificity, even in paucibacillary patients. Despite the small study population and the absence of patients with other dermatological lesions for differential diagnosis, these findings suggest the potential of anti-lipid antibodies as biomarkers for leprosy detection. This approach offers a promising method to improve early diagnosis in high-burden areas, such as the studied municipality in Brazil.<\/jats:p>","DOI":"10.1590\/s1678-9946202567024","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T12:20:40Z","timestamp":1743769240000},"source":"Crossref","is-referenced-by-count":0,"title":["Serum anti-lipid antibodies in patients affected by leprosy in a high-burden municipality in Brazil: a cross-sectional study"],"prefix":"10.1590","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4122-5279","authenticated-orcid":false,"given":"Humberto","family":"Baptista Costa","sequence":"first","affiliation":[{"name":"Universidade Federal do Vale do S\u00e3o Francisco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7629-4963","authenticated-orcid":false,"given":"Filipe Rocha","family":"Lima","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0577-0752","authenticated-orcid":false,"given":"Igor Gabriel","family":"Meneses Lima","sequence":"additional","affiliation":[{"name":"Universidade Federal do Vale do S\u00e3o Francisco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1752-0542","authenticated-orcid":false,"given":"S\u00e1vio Breno Pires","family":"Brito","sequence":"additional","affiliation":[{"name":"Universidade Federal do Vale do S\u00e3o Francisco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7509-4625","authenticated-orcid":false,"given":"Julia","family":"Bitencourt","sequence":"additional","affiliation":[{"name":"Instituto de Tecnologia em Sa\u00fade,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-6339","authenticated-orcid":false,"given":"S\u00e9rgio","family":"Arruda","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz,  Brazil; Universidade Estadual da Bahia,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5660-7766","authenticated-orcid":false,"given":"Iukary","family":"Takenami","sequence":"additional","affiliation":[{"name":"Universidade Federal do Vale do S\u00e3o Francisco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"year":"2021","series-title":"Towards zero leprosy: global leprosy (Hansen's disease) strategy 2021\u20132030","key":"ref1"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2019.12.080","article-title":"Leprosy: clinical aspects and diagnostic techniques","volume":"83","author":"Maymone MB","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4102\/safp.v63i1.5311","article-title":"Leprosy review","volume":"63","author":"Makhakhe L","year":"2021","journal-title":"S Afr Fam Pract"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.diagmicrobio.2018.03.002","article-title":"Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?","volume":"91","author":"Devides AC","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"850886","DOI":"10.3389\/fitd.2022.850886","article-title":"NDO-BSA, LID-1, and NDO-LID antibody responses for infection and RLEP by quantitative PCR as a confirmatory test for early leprosy diagnosis","volume":"3","author":"Gobbo AR","year":"2022","journal-title":"Front Trop Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cmi.2019.05.020","article-title":"Diagnostic accuracy of tests for leprosy: a systematic review and meta-analysis","volume":"25","author":"Gurung P","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"792617","DOI":"10.3389\/fcimb.2022.792617","article-title":"Using omics to study leprosy, tuberculosis, and other mycobacterial diseases","volume":"12","author":"Ahamad N","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fimmu.2018.00134","article-title":"Host lipid mediators in leprosy: the hypothesized contributions to pathogenesis","volume":"9","author":"Silva CA","year":"2018","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jiph.2019.12.011","article-title":"Diagnostic accuracy of tests using recombinant protein antigens of Mycobacterium leprae for leprosy: a systematic review","volume":"13","author":"Oliveira AL","year":"2020","journal-title":"J Infect Public Health"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/096120339400300615","article-title":"Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy","volume":"3","author":"Hojnik M","year":"1994","journal-title":"Lupus"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02031064","article-title":"Anticardiolipin antibodies in patients with infectious diseases","volume":"8","author":"Santiago MB","year":"1989","journal-title":"Clin Rheumatol"},{"key":"ref12","first-page":"307","article-title":"Anticardiolipin antibodies in leprosy","volume":"66","author":"Thawani G","year":"1994","journal-title":"Indian J Lepr"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41598-022-27256-x","article-title":"Long-term presence of autoantibodies in plasma of cured leprosy patients","volume":"13","author":"Yang X","year":"2023","journal-title":"Sci Rep"},{"key":"ref14","first-page":"1","article-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade e Ambiente. Hansen\u00edase 2024","year":"2024","journal-title":"Bol Epidemiol"},{"series-title":"Brasil\/Bahia\/Salvador","key":"ref15"},{"volume-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Doen\u00e7as de Condi\u00e7\u00f5es Cr\u00f4nicas e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis","year":"2022","series-title":"Protocolo cl\u00ednico e diretrizes terap\u00eauticas da hansen\u00edase","key":"ref16"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.5588\/ijtld.17.0874","article-title":"Serum antiphospholipid antibody levels as biomarkers for diagnosis of pulmonary tuberculosis patients","volume":"22","author":"Takenami I","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1048759","DOI":"10.3389\/fmed.2023.1048759","article-title":"Serological testing for Hansen's disease diagnosis: clinical significance and performance of IgA, IgM, and IgG antibodies against Mce1A protein","volume":"10","author":"Lima FR","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"101960","DOI":"10.1016\/j.tube.2020.101960","article-title":"Serological biomarkers for monitoring response to treatment of pulmonary and extrapulmonary tuberculosis in children and adolescents","volume":"123","author":"Santos DC","year":"2020","journal-title":"Tuberculosis (Edinb)"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tube.2012.02.004","article-title":"Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response","volume":"92","author":"Goodridge A","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt PM","year":"2015","journal-title":"BMJ"},{"key":"ref22","article-title":"Prospects for new leprosy diagnostic tools, a narrative review considering ELISA and PCR assays","volume":"53","author":"Gama RS","year":"2020","journal-title":"Rev Soc Bras Med Trop."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/trstmh\/trz089","article-title":"Evaluation of antibody detection against the NDO-BSA, LID-1 and NDO-LID antigens as confirmatory tests to support the diagnosis of leprosy in Yunnan province, southwest China","volume":"114","author":"Jian L","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12879-018-3653-0","article-title":"Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil","volume":"19","author":"Leturiondo AL","year":"2019","journal-title":"BMC Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10989-019-09936-x","article-title":"Identification of drug and vaccine target in Mycobacterium leprae: a reverse vaccinology approach","volume":"26","author":"Gupta E","year":"2020","journal-title":"Int J Pept Res Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"17920","DOI":"10.1038\/s41598-018-36323-1","article-title":"Evaluation of immunodiagnostic tests for leprosy in Brazil, China and Ethiopia","volume":"8","author":"van Hooij A","year":"2018","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s42358-019-0094-4","article-title":"Epidemiological, clinical and immune factors that influence the persistence of antiphospholipid antibodies in leprosy","volume":"59","author":"Ribeiro SL","year":"2019","journal-title":"Adv Rheumatol"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001580","article-title":"Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review","volume":"7","author":"Taha M","year":"2021","journal-title":"RMD Open."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"100041","DOI":"10.1016\/j.rpth.2023.100041","article-title":"Outcomes associated with antiphospholipid antibodies in COVID-19: a prospective cohort study","volume":"7","author":"Mendel A","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1128\/IAI.66.6.2625-2631.1998","article-title":"Mapping and identification of the major cell wall-associated components of Mycobacterium leprae","volume":"66","author":"Marques MA","year":"1998","journal-title":"Infect Immun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4049\/jimmunol.178.1.338","article-title":"Mycobacterium leprae inhibits dendritic cell activation and maturation","volume":"178","author":"Murray RA","year":"2007","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/20477724.2021.2021045","article-title":"Can anti-PGL-I antibody isotypes differentiate leprosy contacts and leprosy patients?","volume":"116","author":"Albuquerque AA","year":"2022","journal-title":"Pathog Glob Health"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"698495","DOI":"10.3389\/fmed.2021.698495","article-title":"Serum IgA antibodies specific to M. leprae antigens as biomarkers for leprosy detection and household contact tracking","volume":"8","author":"Silva KK","year":"2021","journal-title":"Front Med"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652025000100211&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T12:21:09Z","timestamp":1743769269000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652025000100211&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"alternative-id":["S0036-46652025000100211"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202567024","relation":{},"ISSN":["1678-9946"],"issn-type":[{"type":"electronic","value":"1678-9946"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e24"}}